Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Chugai Pharmaceutical Co ( (JP:4519) ) just unveiled an announcement.
In its 2024 financial results, Chugai Pharmaceutical reported a notable increase in revenues and profits, with a 5.3% rise in revenues and a 23.4% increase in operating profit compared to the previous year. The company also announced a significant increase in dividends, reflecting its strong financial performance and marking its 100th anniversary with special dividends, indicating a positive outlook for shareholders.
More about Chugai Pharmaceutical Co
Chugai Pharmaceutical Co., Ltd., listed on the Tokyo Stock Exchange, operates in the pharmaceutical industry. The company is known for developing and marketing innovative medicines, focusing on oncology, rheumatology, and renal diseases.
YTD Price Performance: -7.82%
Average Trading Volume: 7,366
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $67.98B
For a thorough assessment of 4519 stock, go to TipRanks’ Stock Analysis page.
